DIA
Drug Information Association Logo
« Back to Listing

Functional Service Provider Relationships: Critical Factors to Ensuring Long-Term Success

Track:
Innovative Partnering Models and Outsourcing Strategies

Day & Time:
June 18, 1:30PM - 3:00PM (Pacific Standard Time)

Session Number:
356

Room Number:
4

Level:
Intermediate

Type:
Forum

Title:
Functional Service Provider Relationships: Critical Factors to Ensuring Long-Term Success

Chair(s):
Andrew Townshend
Vice President, Alliance Development
INC Research, United States

Description:
Functional service provider (FSP) partnerships are interpreted differently across the industry. This forum brings together experts to offer varying views on how to develop and implement an FSP model and its relative success in driving price reductions, speed, and innovation.


Learning Objective(s):
Define a functional service provider (FSP) model and associated considerations in structuring this type of partnership; Recognize how structures must change both within the CRO and the pharmaceutical partner to support this relationship; Assess the challenges and benefits of converting from one type of partnering model to an FSP relationship and how to manage through the process.

Presentation(s) & Speaker(s):
Panelist
Rose Kidd
VP Clinical Operations, Clinical Research Services
ICON, Ireland

Panelist
Adrian Otte
Vice President, Global Development Operations
Amgen Inc., United States

Panelist
Benjamin Thurmond, JD
FSP Alliance Manager, Global Pharma Procurement
Genentech, A Member of the Roche Group, United States